Skip to NavigationSkip to content

News

0
In the opening period of Shultz's stewardship, it seems he has taken the strategy to implement changes fast and hard – culminating in the decision to...
0
Cancer Research UK has announced that its subsidiary, Cancer Research Technology, and Celgene have agreed a drug discovery collaboration.
0
The Sanofi dengue vaccine scandal continues, Teva hit by 10,000 job losses and Chairman departure, and a "mind-blowing" haemophilia cure? Check out...
0
Novartis has announced that the President of its oncology business, Bruno Strigini, is to retire next year, citing personal reasons for the...

Features

“You don’t need that linear career path – making brave career decisions is actually really valued”.